14th January 2011
Another study is called, “The value of Wilms tumor susceptibility gene 1 in cytologic preparations as a marker for malignant Mesothelioma" by Jonathan L. Hecht M.D., Ph.D., Benjamin H. Lee M.D., Ph.D., Jack L. Pinkus Ph.D., Geraldine S. Pinkus M.D., - Can...
Read >
14th January 2011
Another study is called, “D2-40: A Reliable Marker in the Diagnosis of Pleural Mesothelioma" by Annette M. Müllera, Folker E. Frankeb, Klaus-Michael Müllera - Institute of Pathology, BG Clinics ‘Bergmannsheil’, Ruhr University Bochum, Bochum, and Justus L...
Read >
14th January 2011
Another study is called, “SV40 expression in human neoplastic and non-neoplastic tissues: perspectives on diagnosis, prognosis and therapy of human malignant mesothelioma." By Procopio A, Marinacci R, Marinetti MR, Strizzi L, Paludi D, Iezzi T, Tassi G, C...
Read >
14th January 2011
Another study is called, “Inhibition of mesothelioma cell growth in vitro by doxycycline" Presented at a symposium at the national meeting of the American College of Chest Physicians, Chicago, IL, November 1999. Volume 138, Issue 2, Pages 101-106 (August ...
Read >
14th January 2011
One interesting study is called, “Effects of glycosaminoglycans on proliferation of epithelial and fibroblast human malignant mesothelioma cells: a structure–function relationship" by Christopher Potten, Zbigniew Darzynkiewicz, Kohsuke Sasaki, A. Syrokou,...
Read >
14th January 2011
Another study is called, “The palliative benefits of MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in patients with malignant Mesothelioma" by E. Andreopoulou, P. J. Ross, M. E. R. O'Brien*, H. E. R. Ford, K. Priest, T. Eisen, A. Norton, S. As...
Read >
27th October 2010
One interesting study is called, “Translation of Microarray Data into Clinically Relevant Cancer Diagnostic Tests Using Gene Expression Ratios in Lung Cancer and Mesothelioma" by Gavin J. Gordon, Roderick V. Jensen, Li-Li Hsiao, Steven R. Gullans, Joshua ...
Read >
27th October 2010
Another interesting study is called, “Value of the Mesothelium-Associated Antibodies Thrombomodulin, Cytokeratin 5/6, Calretinin, and CD44H in Distinguishing Epithelioid Pleural Mesothelioma from Adenocarcinoma Metastatic to the Pleura" by P M Cury M.D., ...
Read >
27th October 2010
Another interesting study is called, “Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma." By Ordóñez NG. The University of Texas M.D. Anderson Cancer Center, Houston 77030 - Mod Pathol. 1998 Oct;11(10):...
Read >
27th October 2010
Another interesting study is called, “Utility of D2-40, a novel mesothelial marker, in the diagnosis of malignant Mesothelioma" by Albert Y Chu, Leslie A Litzky, Theresa L Pasha, Geza Acs and Paul J Zhang - Department of Pathology and Laboratory Medicine,...
Read >
27th October 2010
Another interesting study is called, “The value of antibodies 44-3A6, SM3, HBME-1, and thrombomodulin in differentiating epithelial pleural mesothelioma from lung adenocarcinoma a comparative study with other commonly used antibodies" by M. D. Anderson Ca...
Read >
27th October 2010
Another interesting study is called, “The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial" by VW Rusch, S Piantadosi and EC Holmes - Memorial Sloan-Kettering Cancer Center, New York, N.Y. The Journal o...
Read >
27th October 2010
Another interesting study is called, “Simian virus 40 and pleural mesothelioma in humans." By H D Strickler, J J Goedert, M Fleming, W D Travis, A E Williams, C S Rabkin, R W Daniel and K V Shah - Cancer Epidemiology, Biomarkers & Prevention June 1996 5; ...
Read >
27th October 2010
Another interesting study is called, “Randomized trial of doxorubicin versus cyclophosphamide in diffuse malignant pleural Mesothelioma" by Sørensen PG, Bach F, Bork E, Hansen HH - Cancer Treat Rep. 1985 Dec;69(12):1431-2. Here is an excerpt: “Abstract -...
Read >
27th October 2010
Another interesting study is called, “Potential Role of Histone Deacetylase Inhibitors in Mesothelioma: Clinical Experience with Suberoylanilide Hydroxamic Acid Clinical Lung Cancer" - Chest Surg Clin N Am. 1994 Feb;4(1):113-26 - Allen KB, Faber LP, Warre...
Read >